Showing results (291-300 of 303) with videos related to
Sort By:
Pageof 31
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.Cell|July 26, 2016
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesM Gordon Joyce, Adam K Wheatley, Paul V Thomas, et al.Ebiomedicine|May 6, 2023
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineGeorgia Deliyannis, Nicholas A Gherardin, Chinn Yi Wong, et al.Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.Ebiomedicine|November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boosterTerry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.Cell Reports. Medicine|February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responsesMarios Koutsakos, Louise C Rowntree, Luca Hensen, et al.Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.Clinical & Translational Immunology|April 12, 2021
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, et al.Cell Reports. Medicine|April 8, 2023
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cellsThi H O Nguyen, Louise C Rowntree, Lilith F Allen, et al.JCI Insight|April 10, 2023
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbationsJennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, et al.Pageof 31